Dr. Lal Pathlabs gets nod to acquire property in New Delhi

24 Sep 2025 Evaluate

Dr. Lal Pathlabs has received approval from its Board to acquire immovable property situated in New Delhi. The company will enter into Agreement(s) with The South Indian Bank (the Mortgagee/ Lender) and other the Mortgagors/ Borrowers for the acquisition of the property. The company will pay consideration amount of up to Rs 74.51 crore (exclusive of Stamp Duty, Registration Fees, Brokerage/ Commission and other incidental expenses on actual basis). The property comprises four units situated at Plot No. Site-II, District Centre, Shalimar Palace, Shalimar Bagh, New Delhi.

Dr. Lal Pathlabs is a provider of diagnostic and related healthcare tests and services in India.

Dr. Lal Pathlabs Share Price

3025.95 -28.50 (-0.93%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Apollo Hospital Ent. 7189.25
Max Healthcare Inst 1097.95
Narayana Hrudayalay 1916.45
Aster DM Healthcare 635.10
Global Health 1163.75
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×